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Barbiturates are known to frequently cause dermatitis medicamentosa. Soon
after the introduction of barbital in 1903 and phenobarbital in 1911, cases of
dermatitis were reported from the use of these drugs. The etiology of barbiturate
dermatitis remains unknown. Potter and Whitacre expressed the opinion that
long acting barbiturates cause skin eruptions more frequently than short acting
barbiturates. The greatest number of barbiturate dermatitides reported in the
literature are produced by phenobarbital followed by barbital. To illustrate the
incidence of dermatitis due to phenobarbital, Menniger (1), in 1928, reported that
1.2 per cent of 167 patients administered phenobarbital developed a dermatitis.
Huddleston (2) observed 1000 cases of epileptics receiving phenobarbital and
reported that 22 cases or 2.2 per cent developed a dermatitis medicamentosa.
Many cases of barbital dermatitis (3, 4, 5, 6,7,8,9) have also been reported. How-
ever, reports of dermatitis caused by short acting barbiturates are infrequent.
Only isolated reports appear in the literature.
One of the explanations for the greater number of cases of dermatitis medica-
mentosa from long-acting barbiturates than short-acting ones may be the differ-
ence between their distribution in and elimination from the skin. Since no data
on skin levels of barbiturates have been reported in the literature, a study was
performed on guinea pigs to determine the concentration of various barbiturates
in the skin, the length of time that they remained and the relation between
plasma and skin levels. Since phenobarbital is prescribed over long periods of
time, the concentration of barbiturates in the hair was studied.
EXPERThIENTAL
I. A comparison of plasma and skin barbiturate concentrations after administration
of long acting and short acting barbiturates
Guinea pigs weighing 350 to 500 grams were injected intraperitoneally with
aqueous solutions of phenobarbital, barbital, amytal, thiopental, and pento-
barbital with doses ranging from 50 to 150 mg./kg. of body weight. The guinea
pigs were sacrificed at varying intervals of time by fracturing the cervical spine.
Three to 5 ml. of blood were drawn by intracardiac puncture and the blood was
collected in oxalate tubes. The plasma was separated by centrifugation.
Samples of shaved skin were excised from the middorsal region of the back,
and the fascia and fat were carefully trimmed away. The skins were placed in
weighing bottles and the weights of the samples were recorded. To prepare the
skin samples for analyses, it was necessary to remove the water by placing the
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TABLE I
Barbital levels in skin and plasma
DOSE rusE PLASMA (MICRO. WET SKIN I WET SKINNO. (NO.1KG.) CONDITION (flOuRs) GLUSS/ML.) (MICROGRAMS/ /PLASMAcus.)
h-hour levels*
1
2
3
4
75
75
75
75
Light
Light I
Light
Light
92
100
60
102
45
53
37
42
.49
.53
.61
.41
2-hour Ievelsf
1
2
3
4
5
6
50
50
50
150
150
150
Light
Light
Light
Deep
Deep
Deep
2
2
2
5
5
5
54
46
52
134
179
148
47
43
40
143
134
116
.87
.92
.77
1.07
.75
.78
* Wet skin/plasma: Mean = .51 + or — .07.
t Wet skin/plasma: Mean = .86 + or .04.
TABLE II
Phenobarbilal levels in skin and plasma
PLASMA I WET SKINDOSE TThSE I (MIcROG&&us/ (WCR0GL&sss/ WET SKIN!NO. (MG./KG.) CONDITION
I
(HouRs) MI..) j GM.)
PLASMA
s-hour levels5
1
2
3
4
5
6
7
100
100
100
150
150
150
150
Deep
Deep
Medium
Light
Deep
Deep
Deep
'
111
111
104
75
160
142
180
101
98.5
80.5
55
124
108
125
.91
.81
.78
.73
.77
.76
.70
2- to 7-hour levelst
1
2
3
4
5
6
7
8
9
10
11
12
50
50
50
100
100
100
100
100
100
150
150
150
Light
Light
Light
Deep
Light
Deep
Light
Medium
Medium
Deep
Deep
Deep
2
2
2
4
4
7
7
7
7
5
5
5
50
43
41
92
89
96
73
97
90
125
125
112
40
42
34
73
73
87
57
72
72
93
113
81
.79
.97
.83
.78
.82
.91
.78
.74
.80
.74
.90
.73
* Wet skin/plasma: Mean = .77 + or — .06.
t Wet skin/plasma: Mean = .82 + or — .07.
TABLE III
Amytal levels in skin and plasma
PLASMA I WET SKIN IDOSE I TIME (sncRoGRAJSS/ I (MIcRoGcs/ I WET SKIN!NO. (No.1KG.) ONDIflON (HouRs) o&.) PLASMA
h-hour levels*
1
2
3
4
5
6
7
75
75
75
75
75
75
75
Deep
Deep
Deep
Deep
Deep
Deep
Deep
3'
3
3'
3'
53
67
63
56
58
63
60
36
62
51
52
42
37
52
.68
.93
.82
.92
.73
.59
.87
2-hour leveist
1
2
3
4
5
6
7
50
50
50
100
100
100
100
Light
Light
Light
Deep
Deep
Deep
Deep
2
2
2
2
2
2
2
17
15
15
56
52
45
49
11
12
10
33
43
24
30
.65
.80
.70
.59
.78
.55
.60
* Wet skin/plasma: Mean = .79 + or — .04.
f Wet skin/plasma: Mean = .67 + or .09.
TABLE IV
Perdobarbital levels in skin and plasma
PLASMADOSE TIME (MICROGRAMS!NO. (Mo./Ko.) CONorrION (HouRs)
WET SKIN I
(MIcRooRAMs/ WET SKIN/
GM.) PLASMA
s-hour levels*
1
2
3
4
5
6
7
8
9
10
11
12
50
50
50
50
50
50
50
50
50
75
75
75
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
3'
3'j
',
32
39
47.5
36
35
32
40
42
32
73
70
60
30.4
31.0
21.0
19.5
24
27
24
22
27
27
21
20
.95
.80
.44
.54
.67
.83
.60
.53
.83
.36
.30
.32
2-hour leveist
1
2
3
4
5
50
50
50
50
50
Deep
Deep
Deep
Deep
Light
2
2
2
2
2
22
19
21
27
12
15
14
15
11
7
.68
.71
.71
.70
.58
* Wet skin/plasma: Mean .57 + or — .18.
t Wet skin/plasma: Mean = .68 + or — .05.
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weighing bottles with skin in a vacuum oven at 50°C. overnight. The dry weights
were recorded, and the dry skins were powdered in a Wiley mifi. It was necessary
to dry the skin before powdering in a Wiley mill, since wet skin cannot be milled.
A sample of the powdered skin equivalent to 1 to 3 grams of wet skin was used
for analysis. The concentration of barbiturates in the skin was calculated by
dividing the concentration of barbiturates in the dry skin by the
weight of dry skin
weight of wet skin
The barbiturate concentration in the plasma and skin were determined by the
ultraviolet spectrophotometric method of Goldbaum (10). The results are shown
in Tables I to IV.
II. A comparison of the disappearance of barbiturates from plasma and skin
Guinea pigs were injected intraperitoneally with anesthetic doses of repre-
sentative long-acting and short-acting barbiturates. The doses were 150 mg./kg.
for phenobarbital and barbital, 75 mg./kg. for amytal and 50 mg./kg. for thio-
pental and pentobarbital. Samples of blood and skin were collected 3' hour after
the injection as indicated in Experiment I. The skin wounds were closed by skin
clips. Five hours after the injection, samples of blood and skin were again col-
lected. The h-hour and 5-hour specimens of skin and plasma were analyzed for
barbiturates. The results are shown in Tables V and VI.
TABLE V
Thiopental levels in skin and plasma
PLASMA WET SKIN IDOSE I TTh (ucRoGLcs/ (MICROGRAMS! WET SKIN/NO. (MG/KG.) COITION (Ros)
J GM.)
PLASMA
s-hour levels*
1
2
3
4
5
6
7
8
9
50
50
50
50
50
50
50
50
50
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
Deep
3-
3'
3
42
36
25
28
26
30
39
27
33
25
15
11
15
15
20
20
14
17
.58
.41
.39
.52
.55
.63
.47
.48
.49
2-hour leveist
1
2
3
4
50
50
50
50
Medium
Medium
Medium
Medium
2
2
2
2
23
23
23
20
10
10
12
11
.42
.40
.50
.51
* Wet skin/plasma: Mean = .50 + or — .07.
t Wet skin/plasma: Mean .45 + or — .05.
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TABLE VI
A comparison of the barbiturate levels in the plasma and skin at h-hour and 5-hour intervals*
DOSE TIME PLASMA WET SKIN
(MG/KG.) CONDITION (HouRs) (MIcR0GRAMS/ML.) (MICROGRAMS/GM.)
Phenobarhital
150
150
150
Light
Light
Deep
Deep
Deep
Deep
5
5
5
75 55
125 93
160 124
125 113
142 109
112 81
Barbital
150
150
150
Light
Deep
Medium
Deep
Deep
Deep
5
5
5
157
139
211
179
223
148
85
143
186
134
152
116
50
50
50
50
Pentobarbital
Light
Light
Deep
Light
Deep
Light
Deep
Light
5
5
5
5
23
9
36
7
35
12
42
10
7
5
20
3
24
7
22
7
Thiopental
50
50
50
50
Medium
Medium
Deep
Deep
Deep
Deep
Deep
Deep
3
4
4
4
25
21
30
16
27
13
33
14
11
6
20
13
14
10
17
11
Amytal
75 Deep 58 42
Light 5 20 6
75 Deep 53 36
Light 5 15 3
75 Deep 68 37
Light 5 4 5
75 Deep 60 52
Light 5 6 8
* In all cases, the same guinea pig was used for the j-hour and 5-hour specimens.
TABLE VII
Comparison of plasma, skin and hair lrrels for phenobarbital
PLASMA SKIN HAIR TIME (HOURS)DOSE DAYS OF AD-
(OR/DAY) SIINISTRAT1ON (MICROGRAMS/ (MICROGRASIS/ (MICROGRAMS/ SPECIMENSML.) GM.) GM.) COLLECTED
III. Concentrations of phenobarbital in hair of guinea pigs
One group of five guinea pigs was injected intraperitoneally with grain of
phenobarbital daily for five to nine days. The animals were sacrificed by frac-
turing the spine and samples of blood, shaved hair and shaved skin were col-
lected and analyzed for phenobarbital concentrations. In two animals the col-
lections were made 12 hour after the last injection, and in three animals the
collections were made 24 hours after the last injection. Results are shown in
Table VII.
In another group of six guinea pigs, the hair on the back was shaved with an
Oster hair clipper. One-half grain of phenobarbital was injected intraperitoneally
daily for 11 days. An area of the 11-day growth of hair on the back was shaved
and analyzed for phenobarbital. One month after discontinuing the phenobarbi-
tal, a sample of hair was collected again from the same area that contained the
30-day growth after discontinuing phenobarbital, and other samples from another
area which included the 11-day growth plus the 30-day growth after the drug
was discontinued. These samples were analyzed for phenobarbital. Results shown
in Table VIII.
RESULTS AND DISCUSSION
All the five barbiturates were detected in the skin and plasma of guinea pigs
as early as thirty minutes after intraperitoneal administration. After adminis-
tering the same dose, the long-acting barbiturates (barbital and phenobarbital)
attained higher levels in the skin and plasma than the short-acting barbiturates
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9 53.9 47 4000 12
6 37 35 4760 24
6 33 25 295 24
5 280 252 159 12
8 51 48 620 24
TABLE VIII
Phenoharbilat lerels in hair
NO.
1 12
2 ]4
3
4
S
DOSENO. (no/DAY)
1 I
2 II
3
S
6 'ii
DAYS OF
ADMINISTRA-
TiON
11
11
11
11
11
11
HAIR
)MICR0GRAM5/
GM.)
1545
392
508
645
654
235
CONCENTRATION IN
HAIR ONE MONTH
AFTER DISCONTINUING
DRUG
0
0
0
0
0
0
PRES IOUSLY UNSHAS RD
AREA ONE MONTH AFTRR
DISCONTINUING DRUG
MICROGRAMS/GM.)
157
57
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(pentobarbital, thiopental and amytal). In all instances plasma levels were greater
than skin levels. Varying doses did not alter significantly the wet skin to plasma
ratios. With the exception of barbital, the plasma/skin ratios for hour and two
to seven hours were approximately equal for all the barbiturates. With barbital
there was a significant difference between the h-hour and 2-hour concentrations.
This probably indicates that equilibrium between plasma and skin was not
reached in } hour.
The plasma levels reflect the skin levels since they increased with an increase
in the plasma levels and decreased correspondingly with no tendency for the
barbiturates to be bound in the skia.
Phenobarbital was found to enter the hair and was deposited there when the
level was maintained for six or more days. There was no correlation between
concentrations in plasma, skin and hair.
Thirty days after discontinuing the drug, the phenobarbital could no longer
be detected in the 30-day growth of hair in the area previously shaved, but it
could be found in other areas of the same guinea pig, which had not been shaved.
These results indicate that if the plasma phenoharbital concentration is not
maintained long enough for the hair cells to leave the hair bulb, the barbiturates
will be deposited in such low concentrations that they cannot be detected. These
experiments also indicate that there is an equilibrium between the cells of the
germinating layer of the hair bulb and the plasma.
CONCLU5ION5
As stated in the introduction, long-acting barbiturates, especially phenobar-
bital and barbital, are responsible for the greatest number of barbiturate der-
matitides. The results of these experiments reveal that phenobarbital and barbital
have higher plasma and skin concentrations than short-acting barbiturates after
similar doses are administered. After five hours, the long-acting barbiturates
maintained high plasma and skin concentrations while the plasma and skin con-
centrations for the short-acting barbiturates \vere markedly decreased. It is
known that phenobarbital and barbital remain in the body of humans for long
periods of time. An estimated rate of fall in plasma concentration is 20 per cent
(11) every 24 hours. From our studies one may speculate that the same skin/
plasma ratios that are found in guinea pigs are present in humans. The short-
acting barbiturates in humans will fall approximately 35 per cent to 60 per
cent (12) every 24 hours. Thus, the long-acting barbiturates may be present for
longer periods of time in the plasma and skin, and would be more likely to
sensitize.
Further work on this problem is indicated. It would be interesting to separate
the dermis and epidermis in humans to determine the barbiturate concentration
in lesions of dermatitis medicamentosa. In addition, the detection of barbiturates
in hair may be valuable in toxicologic studies.
SUMMARY
Barbiturate levels in the plasma and skin for phenobarbital, barbital, amytal,
pentobarbital and thiopental were determined by spectrophotometric methods,
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and their significance discussed. This may serve as a base line study in deter-
mining the etiology of dermatitis medicamentosa. Phenobarbital levels were also
determined in the hair of guinea pigs.
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